The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Injectable Anthelmintic Drugs Market Research Report 2025
Synopsis
The global Injectable Anthelmintic Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Injectable Anthelmintic Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Injectable Anthelmintic Drugs.
Report Scope
The Injectable Anthelmintic Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Injectable Anthelmintic Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Injectable Anthelmintic Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis
Cipla
Sun Pharmaceutical Industries
Amneal Pharmaceuticals
Zoetis
GlaxoSmithKline
Bayer
Merck
Boehringer Ingelheim International
Segment by Type
Benzimidazoles
Piperazine
Imidazothiazole
Spiroindoles
Others
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Veterinary Pharmacies
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Injectable Anthelmintic Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Injectable Anthelmintic Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Injectable Anthelmintic Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Injectable Anthelmintic Drugs.
Report Scope
The Injectable Anthelmintic Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Injectable Anthelmintic Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Injectable Anthelmintic Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis
Cipla
Sun Pharmaceutical Industries
Amneal Pharmaceuticals
Zoetis
GlaxoSmithKline
Bayer
Merck
Boehringer Ingelheim International
Segment by Type
Benzimidazoles
Piperazine
Imidazothiazole
Spiroindoles
Others
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Veterinary Pharmacies
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Injectable Anthelmintic Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Injectable Anthelmintic Drugs Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Benzimidazoles
1.2.3 Piperazine
1.2.4 Imidazothiazole
1.2.5 Spiroindoles
1.2.6 Others
1.3 Market by Application
1.3.1 Global Injectable Anthelmintic Drugs Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.3.5 Veterinary Pharmacies
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Injectable Anthelmintic Drugs Market Perspective (2019-2030)
2.2 Injectable Anthelmintic Drugs Growth Trends by Region
2.2.1 Global Injectable Anthelmintic Drugs Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Injectable Anthelmintic Drugs Historic Market Size by Region (2019-2024)
2.2.3 Injectable Anthelmintic Drugs Forecasted Market Size by Region (2025-2030)
2.3 Injectable Anthelmintic Drugs Market Dynamics
2.3.1 Injectable Anthelmintic Drugs Industry Trends
2.3.2 Injectable Anthelmintic Drugs Market Drivers
2.3.3 Injectable Anthelmintic Drugs Market Challenges
2.3.4 Injectable Anthelmintic Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Injectable Anthelmintic Drugs Players by Revenue
3.1.1 Global Top Injectable Anthelmintic Drugs Players by Revenue (2019-2024)
3.1.2 Global Injectable Anthelmintic Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Injectable Anthelmintic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Injectable Anthelmintic Drugs Revenue
3.4 Global Injectable Anthelmintic Drugs Market Concentration Ratio
3.4.1 Global Injectable Anthelmintic Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Injectable Anthelmintic Drugs Revenue in 2023
3.5 Injectable Anthelmintic Drugs Key Players Head office and Area Served
3.6 Key Players Injectable Anthelmintic Drugs Product Solution and Service
3.7 Date of Enter into Injectable Anthelmintic Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Injectable Anthelmintic Drugs Breakdown Data by Type
4.1 Global Injectable Anthelmintic Drugs Historic Market Size by Type (2019-2024)
4.2 Global Injectable Anthelmintic Drugs Forecasted Market Size by Type (2025-2030)
5 Injectable Anthelmintic Drugs Breakdown Data by Application
5.1 Global Injectable Anthelmintic Drugs Historic Market Size by Application (2019-2024)
5.2 Global Injectable Anthelmintic Drugs Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Injectable Anthelmintic Drugs Market Size (2019-2030)
6.2 North America Injectable Anthelmintic Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Injectable Anthelmintic Drugs Market Size by Country (2019-2024)
6.4 North America Injectable Anthelmintic Drugs Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Injectable Anthelmintic Drugs Market Size (2019-2030)
7.2 Europe Injectable Anthelmintic Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Injectable Anthelmintic Drugs Market Size by Country (2019-2024)
7.4 Europe Injectable Anthelmintic Drugs Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Injectable Anthelmintic Drugs Market Size (2019-2030)
8.2 Asia-Pacific Injectable Anthelmintic Drugs Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Injectable Anthelmintic Drugs Market Size by Region (2019-2024)
8.4 Asia-Pacific Injectable Anthelmintic Drugs Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Injectable Anthelmintic Drugs Market Size (2019-2030)
9.2 Latin America Injectable Anthelmintic Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Injectable Anthelmintic Drugs Market Size by Country (2019-2024)
9.4 Latin America Injectable Anthelmintic Drugs Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Injectable Anthelmintic Drugs Market Size (2019-2030)
10.2 Middle East & Africa Injectable Anthelmintic Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Injectable Anthelmintic Drugs Market Size by Country (2019-2024)
10.4 Middle East & Africa Injectable Anthelmintic Drugs Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Detail
11.1.2 Novartis Business Overview
11.1.3 Novartis Injectable Anthelmintic Drugs Introduction
11.1.4 Novartis Revenue in Injectable Anthelmintic Drugs Business (2019-2024)
11.1.5 Novartis Recent Development
11.2 Cipla
11.2.1 Cipla Company Detail
11.2.2 Cipla Business Overview
11.2.3 Cipla Injectable Anthelmintic Drugs Introduction
11.2.4 Cipla Revenue in Injectable Anthelmintic Drugs Business (2019-2024)
11.2.5 Cipla Recent Development
11.3 Sun Pharmaceutical Industries
11.3.1 Sun Pharmaceutical Industries Company Detail
11.3.2 Sun Pharmaceutical Industries Business Overview
11.3.3 Sun Pharmaceutical Industries Injectable Anthelmintic Drugs Introduction
11.3.4 Sun Pharmaceutical Industries Revenue in Injectable Anthelmintic Drugs Business (2019-2024)
11.3.5 Sun Pharmaceutical Industries Recent Development
11.4 Amneal Pharmaceuticals
11.4.1 Amneal Pharmaceuticals Company Detail
11.4.2 Amneal Pharmaceuticals Business Overview
11.4.3 Amneal Pharmaceuticals Injectable Anthelmintic Drugs Introduction
11.4.4 Amneal Pharmaceuticals Revenue in Injectable Anthelmintic Drugs Business (2019-2024)
11.4.5 Amneal Pharmaceuticals Recent Development
11.5 Zoetis
11.5.1 Zoetis Company Detail
11.5.2 Zoetis Business Overview
11.5.3 Zoetis Injectable Anthelmintic Drugs Introduction
11.5.4 Zoetis Revenue in Injectable Anthelmintic Drugs Business (2019-2024)
11.5.5 Zoetis Recent Development
11.6 GlaxoSmithKline
11.6.1 GlaxoSmithKline Company Detail
11.6.2 GlaxoSmithKline Business Overview
11.6.3 GlaxoSmithKline Injectable Anthelmintic Drugs Introduction
11.6.4 GlaxoSmithKline Revenue in Injectable Anthelmintic Drugs Business (2019-2024)
11.6.5 GlaxoSmithKline Recent Development
11.7 Bayer
11.7.1 Bayer Company Detail
11.7.2 Bayer Business Overview
11.7.3 Bayer Injectable Anthelmintic Drugs Introduction
11.7.4 Bayer Revenue in Injectable Anthelmintic Drugs Business (2019-2024)
11.7.5 Bayer Recent Development
11.8 Merck
11.8.1 Merck Company Detail
11.8.2 Merck Business Overview
11.8.3 Merck Injectable Anthelmintic Drugs Introduction
11.8.4 Merck Revenue in Injectable Anthelmintic Drugs Business (2019-2024)
11.8.5 Merck Recent Development
11.9 Boehringer Ingelheim International
11.9.1 Boehringer Ingelheim International Company Detail
11.9.2 Boehringer Ingelheim International Business Overview
11.9.3 Boehringer Ingelheim International Injectable Anthelmintic Drugs Introduction
11.9.4 Boehringer Ingelheim International Revenue in Injectable Anthelmintic Drugs Business (2019-2024)
11.9.5 Boehringer Ingelheim International Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Injectable Anthelmintic Drugs Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Benzimidazoles
Table 3. Key Players of Piperazine
Table 4. Key Players of Imidazothiazole
Table 5. Key Players of Spiroindoles
Table 6. Key Players of Others
Table 7. Global Injectable Anthelmintic Drugs Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Injectable Anthelmintic Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Injectable Anthelmintic Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 10. Global Injectable Anthelmintic Drugs Market Share by Region (2019-2024)
Table 11. Global Injectable Anthelmintic Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 12. Global Injectable Anthelmintic Drugs Market Share by Region (2025-2030)
Table 13. Injectable Anthelmintic Drugs Market Trends
Table 14. Injectable Anthelmintic Drugs Market Drivers
Table 15. Injectable Anthelmintic Drugs Market Challenges
Table 16. Injectable Anthelmintic Drugs Market Restraints
Table 17. Global Injectable Anthelmintic Drugs Revenue by Players (2019-2024) & (US$ Million)
Table 18. Global Injectable Anthelmintic Drugs Market Share by Players (2019-2024)
Table 19. Global Top Injectable Anthelmintic Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Injectable Anthelmintic Drugs as of 2023)
Table 20. Ranking of Global Top Injectable Anthelmintic Drugs Companies by Revenue (US$ Million) in 2023
Table 21. Global 5 Largest Players Market Share by Injectable Anthelmintic Drugs Revenue (CR5 and HHI) & (2019-2024)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Injectable Anthelmintic Drugs Product Solution and Service
Table 24. Date of Enter into Injectable Anthelmintic Drugs Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Injectable Anthelmintic Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 27. Global Injectable Anthelmintic Drugs Revenue Market Share by Type (2019-2024)
Table 28. Global Injectable Anthelmintic Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 29. Global Injectable Anthelmintic Drugs Revenue Market Share by Type (2025-2030)
Table 30. Global Injectable Anthelmintic Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 31. Global Injectable Anthelmintic Drugs Revenue Market Share by Application (2019-2024)
Table 32. Global Injectable Anthelmintic Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 33. Global Injectable Anthelmintic Drugs Revenue Market Share by Application (2025-2030)
Table 34. North America Injectable Anthelmintic Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. North America Injectable Anthelmintic Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 36. North America Injectable Anthelmintic Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 37. Europe Injectable Anthelmintic Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Europe Injectable Anthelmintic Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 39. Europe Injectable Anthelmintic Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 40. Asia-Pacific Injectable Anthelmintic Drugs Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 41. Asia-Pacific Injectable Anthelmintic Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 42. Asia-Pacific Injectable Anthelmintic Drugs Market Size by Region (2025-2030) & (US$ Million)
Table 43. Latin America Injectable Anthelmintic Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Latin America Injectable Anthelmintic Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 45. Latin America Injectable Anthelmintic Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 46. Middle East & Africa Injectable Anthelmintic Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 47. Middle East & Africa Injectable Anthelmintic Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 48. Middle East & Africa Injectable Anthelmintic Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 49. Novartis Company Detail
Table 50. Novartis Business Overview
Table 51. Novartis Injectable Anthelmintic Drugs Product
Table 52. Novartis Revenue in Injectable Anthelmintic Drugs Business (2019-2024) & (US$ Million)
Table 53. Novartis Recent Development
Table 54. Cipla Company Detail
Table 55. Cipla Business Overview
Table 56. Cipla Injectable Anthelmintic Drugs Product
Table 57. Cipla Revenue in Injectable Anthelmintic Drugs Business (2019-2024) & (US$ Million)
Table 58. Cipla Recent Development
Table 59. Sun Pharmaceutical Industries Company Detail
Table 60. Sun Pharmaceutical Industries Business Overview
Table 61. Sun Pharmaceutical Industries Injectable Anthelmintic Drugs Product
Table 62. Sun Pharmaceutical Industries Revenue in Injectable Anthelmintic Drugs Business (2019-2024) & (US$ Million)
Table 63. Sun Pharmaceutical Industries Recent Development
Table 64. Amneal Pharmaceuticals Company Detail
Table 65. Amneal Pharmaceuticals Business Overview
Table 66. Amneal Pharmaceuticals Injectable Anthelmintic Drugs Product
Table 67. Amneal Pharmaceuticals Revenue in Injectable Anthelmintic Drugs Business (2019-2024) & (US$ Million)
Table 68. Amneal Pharmaceuticals Recent Development
Table 69. Zoetis Company Detail
Table 70. Zoetis Business Overview
Table 71. Zoetis Injectable Anthelmintic Drugs Product
Table 72. Zoetis Revenue in Injectable Anthelmintic Drugs Business (2019-2024) & (US$ Million)
Table 73. Zoetis Recent Development
Table 74. GlaxoSmithKline Company Detail
Table 75. GlaxoSmithKline Business Overview
Table 76. GlaxoSmithKline Injectable Anthelmintic Drugs Product
Table 77. GlaxoSmithKline Revenue in Injectable Anthelmintic Drugs Business (2019-2024) & (US$ Million)
Table 78. GlaxoSmithKline Recent Development
Table 79. Bayer Company Detail
Table 80. Bayer Business Overview
Table 81. Bayer Injectable Anthelmintic Drugs Product
Table 82. Bayer Revenue in Injectable Anthelmintic Drugs Business (2019-2024) & (US$ Million)
Table 83. Bayer Recent Development
Table 84. Merck Company Detail
Table 85. Merck Business Overview
Table 86. Merck Injectable Anthelmintic Drugs Product
Table 87. Merck Revenue in Injectable Anthelmintic Drugs Business (2019-2024) & (US$ Million)
Table 88. Merck Recent Development
Table 89. Boehringer Ingelheim International Company Detail
Table 90. Boehringer Ingelheim International Business Overview
Table 91. Boehringer Ingelheim International Injectable Anthelmintic Drugs Product
Table 92. Boehringer Ingelheim International Revenue in Injectable Anthelmintic Drugs Business (2019-2024) & (US$ Million)
Table 93. Boehringer Ingelheim International Recent Development
Table 94. Research Programs/Design for This Report
Table 95. Key Data Information from Secondary Sources
Table 96. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Injectable Anthelmintic Drugs Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Injectable Anthelmintic Drugs Market Share by Type: 2023 VS 2030
Figure 3. Benzimidazoles Features
Figure 4. Piperazine Features
Figure 5. Imidazothiazole Features
Figure 6. Spiroindoles Features
Figure 7. Others Features
Figure 8. Global Injectable Anthelmintic Drugs Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Injectable Anthelmintic Drugs Market Share by Application: 2023 VS 2030
Figure 10. Hospital Pharmacies Case Studies
Figure 11. Retail Pharmacies Case Studies
Figure 12. Online Pharmacies Case Studies
Figure 13. Veterinary Pharmacies Case Studies
Figure 14. Others Case Studies
Figure 15. Injectable Anthelmintic Drugs Report Years Considered
Figure 16. Global Injectable Anthelmintic Drugs Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 17. Global Injectable Anthelmintic Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 18. Global Injectable Anthelmintic Drugs Market Share by Region: 2023 VS 2030
Figure 19. Global Injectable Anthelmintic Drugs Market Share by Players in 2023
Figure 20. Global Top Injectable Anthelmintic Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Injectable Anthelmintic Drugs as of 2023)
Figure 21. The Top 10 and 5 Players Market Share by Injectable Anthelmintic Drugs Revenue in 2023
Figure 22. North America Injectable Anthelmintic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. North America Injectable Anthelmintic Drugs Market Share by Country (2019-2030)
Figure 24. United States Injectable Anthelmintic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Canada Injectable Anthelmintic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Injectable Anthelmintic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Europe Injectable Anthelmintic Drugs Market Share by Country (2019-2030)
Figure 28. Germany Injectable Anthelmintic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. France Injectable Anthelmintic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. U.K. Injectable Anthelmintic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Italy Injectable Anthelmintic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Russia Injectable Anthelmintic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Nordic Countries Injectable Anthelmintic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific Injectable Anthelmintic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Asia-Pacific Injectable Anthelmintic Drugs Market Share by Region (2019-2030)
Figure 36. China Injectable Anthelmintic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Japan Injectable Anthelmintic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. South Korea Injectable Anthelmintic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Southeast Asia Injectable Anthelmintic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. India Injectable Anthelmintic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Australia Injectable Anthelmintic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Latin America Injectable Anthelmintic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Latin America Injectable Anthelmintic Drugs Market Share by Country (2019-2030)
Figure 44. Mexico Injectable Anthelmintic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Brazil Injectable Anthelmintic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Injectable Anthelmintic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa Injectable Anthelmintic Drugs Market Share by Country (2019-2030)
Figure 48. Turkey Injectable Anthelmintic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Saudi Arabia Injectable Anthelmintic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. Novartis Revenue Growth Rate in Injectable Anthelmintic Drugs Business (2019-2024)
Figure 51. Cipla Revenue Growth Rate in Injectable Anthelmintic Drugs Business (2019-2024)
Figure 52. Sun Pharmaceutical Industries Revenue Growth Rate in Injectable Anthelmintic Drugs Business (2019-2024)
Figure 53. Amneal Pharmaceuticals Revenue Growth Rate in Injectable Anthelmintic Drugs Business (2019-2024)
Figure 54. Zoetis Revenue Growth Rate in Injectable Anthelmintic Drugs Business (2019-2024)
Figure 55. GlaxoSmithKline Revenue Growth Rate in Injectable Anthelmintic Drugs Business (2019-2024)
Figure 56. Bayer Revenue Growth Rate in Injectable Anthelmintic Drugs Business (2019-2024)
Figure 57. Merck Revenue Growth Rate in Injectable Anthelmintic Drugs Business (2019-2024)
Figure 58. Boehringer Ingelheim International Revenue Growth Rate in Injectable Anthelmintic Drugs Business (2019-2024)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
